Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.
Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.
Conzen, Suzanne
All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.
All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies. Blood Rev. 2015 Mar; 29(2):71-80.
View in:
PubMed
subject areas
Animals
Diabetes Mellitus, Type 2
Hematologic Neoplasms
Humans
Insulin Resistance
Lipid Metabolism
Metabolic Syndrome
Obesity
Signal Transduction
authors with profiles
Brian Kim